Lipid Emulsion Infusion and COVID-19 Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Investigators suggest that early administration of intravenous lipid emulsion (ILE) affect the inflammatory response and improve outcome in COVID-19. The aim of this trial is to study the effect of fish-oil-based intravenous lipid emulsion (FOBLE) supplementation added to enteral nutrition on shift to ICU for upgrading oxygenation \&/or ventilation in moderate cases of Covid-19 diseased patients requiring only supplemental oxygen in form of simple nasal cannula or venturi mask oxygen (during 7 days admission).
Epistemonikos ID: 56a1449f034cf232406ee9f9e971a7287d1fc681
First added on: Jul 13, 2021